Axiobionics, LLC – FDA 483, Nov 22, 2024
Axiobionics, LLC in Ann Arbor, MI, a medical device establishment, was cited for significant quality system deficiencies during an FDA inspection. Observations included a repeat finding for inadequate management reviews, failure to investigate a complaint involving patient burns from a BioShortZ device, and poorly established corrective and preventive action procedures with open CAPAs lacking target dates. These issues indicate a systemic breakdown in maintaining an effective quality management system.
- Office
- Detroit District Office
- Person
ID · 34feb33d-4ca8-4cc0-8245-230f6dede1c0
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.